GenMark Diagnostics Reports Q2 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
GenMark Diagnostics (GNMK) Tops Q2 EPS by 3c
July 28, 2016 5:44 PM EDTGenMark Diagnostics (NASDAQ: GNMK) reported Q2 EPS of ($0.30), $0.03 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $12.5 million versus the consensus estimate of $9.62 million.
XT-8 continues to deliver strong results. Our second quarter revenues were once again mainly driven... More
